This observation could suggest that the increased circulating levels found in patients with cancer are not solely the result of an increased amount of uPAR being shed from the primary tumour tissue, but perhaps from micrometastases and/or inflammatory tissue in response to the cancer. The gene discussed is PLAUR; the disease is neoplasm.